Breaking News

Particle Sciences to Open New Commercial Facility

$60 million investment is part of an overall business unit expansion that's expected to increase employment by 30%

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Particle Sciences, a Lubrizol LifeSciences company, is opening a new commercial drug product manufacturing facility at the end of 4Q18 at its existing site in Bethlehem, PA. The $60 million investment is part of an overall business unit expansion that’s expected to increase employment by 30 percent with jobs ranging from production and quality control positions to support functions such as analytical services.   The 5,000 sq.-ft. facility will leverage Particle Sciences’ complex formulat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters